Long COVID and Its Associations With Health Outcomes in Older Adults
Condition(s) studied
Investigational drug(s) / intervention(s)
no interventions: This is an observational study without any intervention.
Study summary
The Peking University Health Cohort in Anning, Yunnan (PKUHC-AN) is a prospective cohort study carried out in Anning, Yunnan. The primary aim of this study is to investigate the impact of COVID-19 on older adults' health, and to provide high-quality evidence of real world research for the optimization of prevention and control strategies of COVID-19 and other emerging infectious diseases. Data will be collected regarding health status, history of COVID-19 infections and vaccines, lifestyle and socioeconomic characteristics, as well as the short- and long-term health outcomes.
Eligibility
Primary outcome measure(s)
- Incidence of long COVID — From baseline until the date of long COVID symptoms or date of death from any cause, whichever came first, assessed up to 12 months.
The proportion of participants incurred any symptoms or diagnosed diseases of post-COVID in all infected participants.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Anning medical community | Kunming | Yunan |
More Peking University trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05825651 on ClinicalTrials.gov ↗ ← All trials in China